Division of Cardiovascular Prevention and Wellness, Department of Cardiology, Houston Methodist DeBakey Heart & Vascular Center, Houston, Texas, USA; Center for Outcomes Research, Houston Methodist, Houston, Texas, USA. Electronic address: https://twitter.com/miguelcainzos23.
Lynda K. and David M. Underwood Center for Digestive Disorders, Houston Methodist Hospital and Weill Cornell Medical College, Houston, Texas, USA; Fondren IBD Program, Lynda K. and David M. Underwood Center for Digestive Disorders, Houston Methodist Hospital and Weill Cornell Medical College, Houston, Texas, USA.
J Am Coll Cardiol. 2020 Dec 15;76(24):2895-2905. doi: 10.1016/j.jacc.2020.10.027.
Chronic inflammatory diseases including human immunodeficiency virus infection, psoriasis, rheumatoid arthritis, and systemic lupus erythematosus predispose to atherosclerotic cardiovascular disease (ASCVD). Inflammatory bowel disease (IBD) is a common chronic inflammatory condition, and the United States has the highest prevalence worldwide. IBD has so far been overlooked as a contributor to the burden of ASCVD among young and middle-age adults, but meta-analyses of cohort studies suggest that IBD is an independent risk factor for ASCVD. This review discusses the epidemiological links between IBD and ASCVD and potential mechanisms underlying these associations. ASCVD risk management of patients with IBD is challenging because of their young age and the inability of current risk scores to fully capture their increased risk. The role of IBD in current primary prevention guidelines is evaluated, and strategies for enhanced ASCVD risk reduction in patients with IBD are outlined. Finally, the authors discuss knowledge gaps and future research directions in this innovative field.
慢性炎症性疾病,包括人类免疫缺陷病毒感染、银屑病、类风湿关节炎和系统性红斑狼疮,可导致动脉粥样硬化性心血管疾病(ASCVD)。炎症性肠病(IBD)是一种常见的慢性炎症性疾病,而美国的发病率在全球范围内最高。IBD 迄今为止一直被忽视为年轻人和中年人 ASCVD 负担的一个促成因素,但队列研究的荟萃分析表明,IBD 是 ASCVD 的一个独立危险因素。本文讨论了 IBD 和 ASCVD 之间的流行病学联系以及这些关联的潜在机制。由于患者年龄较轻,且目前的风险评分无法充分捕捉到他们的风险增加,因此对 IBD 患者的 ASCVD 风险管理具有挑战性。评估了 IBD 在现行一级预防指南中的作用,并概述了针对 IBD 患者强化 ASCVD 风险降低的策略。最后,作者讨论了这一创新领域的知识空白和未来研究方向。